π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Apathy is a neurocognitive syndrome characterized by reduced goal-directed ...
Status
Recruiting
Location
Bordeaux University Hospital
Start Date
2021-04-13
Trial ID
NCT03998852
Squamous cell carcinoma (SCC) could be a very aggressive cancer and has a b...
Status
Unknown
Location
CHU Amiens
Start Date
2024-03-27
Trial ID
NCT06450080
Treatments Being Tested
Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's diseas...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT00249080
Glioblastoma multiforme (GBM) is the most common primary brain tumor, and i...
Status
Not Yet Recruiting
Location
CHU Amiens
Start Date
2025-12
Trial ID
NCT07211841
Treatments Being Tested
Since January 2010, a new magnetic resonance imaging scanner (Philips 3T, A...
Status
Completed
Location
Inserm U825
Start Date
2012-06-08
Trial ID
NCT05090956
Treatments Being Tested
To assess the neurocognitive outcomes in patients treated with chemotherapy...
Status
Completed
Location
Gustave Roussy
Start Date
2021-03-19
Trial ID
NCT05071001
Treatments Being Tested
This study will examine whether a new drug called acamprosate can be helpfu...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2005-03
Trial ID
NCT00106106
Treatments Being Tested
The goal of this study is to obtain gamma-aminobutyric acid (GABA) and glut...
Status
Enrolling By Invitation
Location
The Children's Hospital of Philadelphia
Start Date
2024-05-08
Trial ID
NCT07635030
Treatments Being Tested
Gilles de la Tourette syndrome (GTS; also known as Tourette syndrome) is a ...
Status
Completed
Location
Max Planck Institute for Human Cognitive and Brain Sciences
Start Date
2022-05-04
Trial ID
NCT05232955
Treatments Being Tested
The Investigators will examine the disease specificity of 2-hydroxyglutarat...
Status
Completed
Location
UT Southwestern Medical Center
Start Date
2014-01
Trial ID
NCT02731521
Treatments Being Tested